- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A member of the public alleged POM promotional panels at ExCeL London were visible/readable from a public coffee area. Panel found the…
Lilly challenged Roche’s use of “first-line maintenance” for Tarceva across a leavepiece, ad and sponsored feature. Panel found breaches, but the Appeal…
A sponsored HSJ ‘special report’ on atrial fibrillation looked like independent editorial and favoured dronedarone. PMCPA ruled Sanofi-Aventis was inextricably linked to…
A consultant challenged an Asacol leavepiece claiming “up to 72% treatment success”. The Panel found breaches, but on appeal the Appeal Board…
Alcon’s Travatan BAK-free ad used a thornless rose and animal/in vitro data implying better tolerability vs BAK formulation. PMCPA found the ad…
BMJ analysis suggested 3 Ipsen trials were missing EUCTR results. Panel found 2 trials had no UK nexus and 1 was cancelled…
Abbott disclosed that one representative had not taken/passed the ABPI Medical Representatives Examination after exemptions ended in 2006. PMCPA ruled a breach…
Two public complaints said an Onglyza advertorial in Health Service Journal was inappropriate/too technical and potentially public-facing. Panel found a Clause 11.1…
PMCPA case AUTH/3117/11/18 (Director v Seqirus) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…
A health professional challenged an incorrect Disclosure UK entry showing MSD provided financial support. The Panel found the disclosure inaccurate and misleading,…
ViiV and the PMCPA Director complained that Gilead continued to display a Biktarvy tolerability claim on a UK-accessible website after giving an…
Allergan reposted Instagram Stories and employee posts that included Botox pack shots and an “Injectable Product of the Year” reference. The Panel…
An ex-employee alleged Daiichi-Sankyo grossly underreported conference-related transfers of value on Disclosure UK (2016–2018). The Panel found multiple disclosure and record-keeping breaches,…
Colonis admitted a promotional letter for Melatonin 1mg/ml Oral Solution included prescribing information for Melatonin 3mg tablets. The Panel ruled breaches including…
GSK funded a patient-organisation-hosted taskforce. PMCPA found sponsorship disclosure wasn’t clear “from the outset” because it was only accessible via small footer…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.